Source:http://linkedlifedata.com/resource/pubmed/id/21429010
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-6-9
|
pubmed:abstractText |
Liver transplant (LT) outcomes are reported to be improving in non-HCV recipients but not for those infected with HCV. Our aim was to evaluate graft survival and predictors of outcome in HCV and non-HCV patients before and after 2003. Patients with primary LT between February 1, 1998, and December 31, 2005, were included. Patients were divided into Era 1 (1998-2002) and Era 2 (2003-2005) with follow-up through May 31, 2009. Graft survival was compared for HCV, non-HCV, and all patients. There was significant improvement in graft survival in Era 2 for HCV patients. Graft survival in Era 2 of HCV patients was equivalent to non-HCV patients. The most significant improvement between eras was in outcomes of grafts from donors ?60?yr with three-yr graft survival 58.6 (51.3-65.9) vs. 75.4 (68.9-81.9), p = 0.002. The use of donors ?60 did not change between eras: 31% vs. 34%; however, utilization in HCV recipients decreased from 36% to 3% (p < 0.001). In conclusion, graft survival of HCV patients has improved significantly since 2003 and was comparable to non-HCV patients up to three yr. The change in management of donor organs into HCV and non-HCV patients likely contributed to this outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1399-0012
|
pubmed:author |
pubmed-author:Aranda-MichelJaimeJ,
pubmed-author:BonattiHugoH,
pubmed-author:DicksonRolland CRC,
pubmed-author:GhabrilMarwanM,
pubmed-author:KeavenyAndrew PAP,
pubmed-author:KramerDavid JDJ,
pubmed-author:NguyenJustin HJH,
pubmed-author:PungpapongSurakitS,
pubmed-author:SatyanarayanaRajR,
pubmed-author:TanerC BurcinCB
|
pubmed:copyrightInfo |
© 2011 John Wiley & Sons A/S.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E345-55
|
pubmed:meshHeading |
pubmed-meshheading:21429010-Cohort Studies,
pubmed-meshheading:21429010-Female,
pubmed-meshheading:21429010-Follow-Up Studies,
pubmed-meshheading:21429010-Graft Rejection,
pubmed-meshheading:21429010-Graft Survival,
pubmed-meshheading:21429010-Hepacivirus,
pubmed-meshheading:21429010-Hepatitis C,
pubmed-meshheading:21429010-Humans,
pubmed-meshheading:21429010-Liver Diseases,
pubmed-meshheading:21429010-Liver Transplantation,
pubmed-meshheading:21429010-Male,
pubmed-meshheading:21429010-Middle Aged,
pubmed-meshheading:21429010-Retrospective Studies,
pubmed-meshheading:21429010-Survival Rate,
pubmed-meshheading:21429010-Tissue Donors,
pubmed-meshheading:21429010-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Improving graft survival for patients undergoing liver transplantation.
|
pubmed:affiliation |
Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA. Rolland.C.Dickson@Hitchcock.Org
|
pubmed:publicationType |
Journal Article,
Comparative Study
|